Cargando…

High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer

Gastric cancer is an intractable disease with a poor prognosis and limited treatment options. Its treatment remains a major clinical challenge worldwide. Ephrin-B2 is upregulated and involved in tumor growth in various types of cancer. However, the association between ephrin-B2 and prognosis of gast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Wen-Jing, Liu, Yi-Pin, Li, Ming, Liu, Cheng-Xia, Mou, Shao-Jia, Li, Qian-Kun, Chen, Zi-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126187/ https://www.ncbi.nlm.nih.gov/pubmed/30214580 http://dx.doi.org/10.3892/ol.2018.9202

Ejemplares similares

Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer
por: Kong, Fanming, et al.
Publicado: (2016)

High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis
por: Ma, Ying-Yu, et al.
Publicado: (2017)

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
por: Li, Xuelu, et al.
Publicado: (2017)

Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer
por: Zhou, Shao-jie, et al.
Publicado: (2014)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Associated with Poor Prognosis in Gastric Cancer
por: Wang, Da, et al.
Publicado: (2015)

High Level of COP1 Expression is Associated with Poor Prognosis in Primary Gastric Cancer
por: Li, Yuan-fang, et al.
Publicado: (2012)

Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer
por: Wu, Yijun, et al.
Publicado: (2012)

Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer
por: Ye, Heng, et al.
Publicado: (2016)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer
por: Ke, Shouyu, et al.
Publicado: (2022)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021)

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Publicado: (2017)

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
por: He, Jun, et al.
Publicado: (2016)

Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer
por: Li, Shibao, et al.
Publicado: (2018)

The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report
por: Xia, Jie, et al.
Publicado: (2018)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer
por: Hu, Hao, et al.
Publicado: (2018)

Reduced Expression of ZDHHC2 Is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma
por: Yan, Shu-Mei, et al.
Publicado: (2013)

High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients
por: Wang, Hua, et al.
Publicado: (2016)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
por: Wang, Hua, et al.
Publicado: (2015)

Serum albumin levels and serum albumin-globulin ratio are associated with poor prognosis in glioblastoma
por: Yalikun, Kugeluke, et al.
Publicado: (2020)

Correlation of Serum IL-17, VEGF, and Lactate Dehydrogenase (LDH) Levels with Prognosis of Gastric Cancer
por: Rao, Shumei, et al.
Publicado: (2022)

Low Expression of CDK5 and p27 Are Associated with Poor Prognosis in Patients with Gastric Cancer
por: Sun, Yu-Qin, et al.
Publicado: (2016)

Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric cancer patients
por: Lin, Mi, et al.
Publicado: (2022)

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
por: Lu, Jianjun, et al.
Publicado: (2016)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma
por: Li, Guo, et al.
Publicado: (2012)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer
por: Li, Shen, et al.
Publicado: (2015)

Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis
por: Wu, Ping, et al.
Publicado: (2020)

Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer
por: Xia, Shujing, et al.
Publicado: (2019)

Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer
por: Wang, Shuoshan, et al.
Publicado: (2023)

A review on Eph/ephrin, angiogenesis and lymphangiogenesis in gastric, colorectal and pancreatic cancers
por: Rudno-Rudzińska, Julia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ls728g60699oroanigbhaeqtif